The TCR is part of a complex signalling machinery which includes the
TCRalpha beta dimer, the accessory molecules CD4 or CD8 and a signal
transduction module made up of various chains (CD3).

Engagement of the TCR by peptide antigen, in association with MHC gene
products, leads to a series of intracellular biochemical events
culminating in the transcription of new genes and cellular activation. The
earliest identifiable intracellular change documented at present is the
activation of one or more tyrosine kinases that phosphorylate first the
CD3 chains themselves and subsequently other substrates. Subsequent to
tyrosine kinase activation a series of secondary events have been observed
to follow TCR engagement, including activation of serine/threonine kinases,
activation of the GTP-binding protein p21ras and activation of
transcription factors for receptors and growth factors such as the major T
cell growth factor interleukin-2 (IL2). The CD4 and CD8
co-receptors bind a tyrosine kinase (p56lck) via their intracytoplasmic
tail which plays a critical role in T cell signalling.
|